A similar T effector IFNγ gene signature was investigated in NSCLC patients treated with anti-PD-L1 (n = 142), and high expression of the signature at baseline correlated with improved overall survival (Fehrenbacher et al. 2016). Here, CD274 is linked to non-small cell lung carcinoma.